Author

R. Franco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

G. Navarro· 2 shared D. Aguinaga· 1 shared E. I. Canela· 1 shared H. A. Alkozi· 1 shared I. Reyes-Resina· 1 shared J. J. Pintor· 1 shared J. L. Beltran· 1 shared J. Sanchez-Naves· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

G. Navarro

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The meaning of the Michaelis-Menten constant: Km describes a steady-state.

E. I. Canela, G. Navarro, J. L. Beltran, R. Franco

The paper clarifies that the Michaelis-Menten constant (Km) defines the steady state in enzyme kinetics, not the substrate dissociation constant (Kd), and emphasizes the importance of the association rate (k1) in physiological contexts.

bioRxiv · May 15, 2019 · PreprintBiochemistry

Adrenergic-melatonin heteroreceptor complexes are key in controlling ion homeostasis and intraocular eye pressure and their disruption contributes to hypertensive glaucoma

H. A. Alkozi, G. Navarro, D. Aguinaga, I. Reyes-Resina, J. Sanchez-Naves, M. J. Perez de Lara, R. Franco, J. J. Pintor

The paper shows that disruption of adrenergic-melatonin receptor complexes contributes to glaucoma by affecting ion homeostasis and intraocular pressure, and suggests a therapeutic approach using melatonin and prazosin.

bioRxiv · May 14, 2019Physiology